Clinical Trial Update: Phase II Study of Minocycline for Reducing Symptom Burden in Colorectal Patients [Phase 2]

View source ↗

Summary

Phase II study evaluating minocycline to reduce symptom burden in colorectal cancer patients has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Minocycline (minocycline)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-03-17